cefozopran
Sign in to saveAlso known as SCE 2787, cefozoprán, céfozopran, cefozopranum
Cefozopran (INN) is a fourth-generation cephalosporin.
Research
203 papers- Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2015
- The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2004
- Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteers.Drugs in R&D · 2015
- Stability of cefozopran hydrochloride in aqueous solutions.Drug development and industrial pharmacy · 2016
- On the isomerisation of cefozopran in solution.European journal of medicinal chemistry · 2010
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- Spectrum of bacterial susceptibility and resistance
- References
Cefozopran (INN) is a fourth-generation cephalosporin.
==Spectrum of bacterial susceptibility and resistance== Most of the strains of Stenotrophomonas maltophilia have developed resistance toward cefozopran.
Excerpted from Wikipedia’s “cefozopran” article, available under the CC BY-SA 4.0 licence.
Available in 9 languages
via Wikidata sitelinks · CC0